Improving Clinical Risk Stratification at Diagnosis in Primary Prostate Cancer: A Prognostic Modelling Study.

Improving Clinical Risk Stratification at Diagnosis in Primary Prostate Cancer: A Prognostic Modelling Study.

Over 80% of the nearly 1 million men diagnosed with prostate cancer annually worldwide present with localised or locally advanced non-metastatic disease. Risk stratification is the cornerstone for clinical decision making and treatment selection for these men. The most widely applied stratification...

Full description

Bibliographic Details
Main Authors:	Vincent J Gnanapragasam, Artitaya Lophatananon, Karen A Wright, Kenneth R Muir, Anna Gavin, David C Greenberg
Format:	Article
Language:	English
Published:	Public Library of Science (PLoS) 2016-08-01
Series:	PLoS Medicine
Online Access:	http://europepmc.org/articles/PMC4970710?pdf=render

Similar Items

Trends and outcome from radical therapy for primary non-metastatic prostate cancer in a UK population.
by: David C Greenberg, et al.
Published: (2015-01-01)

Assessing the impact of MRI based diagnostics on pre-treatment disease classification and prognostic model performance in men diagnosed with new prostate cancer from an unscreened population
by: Artitaya Lophatananon, et al.
Published: (2022-08-01)

An Integrative Pancreatic Cancer Risk Prediction Model in the UK Biobank
by: Te-Min Ke, et al.
Published: (2023-12-01)

Risk Factors Associated with Pancreatic Cancer in the UK Biobank Cohort
by: Te-Min Ke, et al.
Published: (2022-10-01)

Composite risk stratification models optimise the value of imaging in prostate cancer staging
by: Tom McAllister, et al.
Published: (2023-09-01)

Risk of breast cancer in the UK biobank female cohort and its relationship to anthropometric and reproductive factors.
by: Kawthar Al-Ajmi, et al.
Published: (2018-01-01)

Risk stratification for prostate cancer management: value of the Cambridge Prognostic Group classification for assessing treatment allocation
by: M. G. Parry, et al.
Published: (2020-05-01)

Exploring the causal role of the immune response to varicella-zoster virus on multiple traits: a phenome-wide Mendelian randomization study
by: Xinzhu Yu, et al.
Published: (2023-04-01)

Prostate kallikrein markers in diagnosis, risk stratification and prognosis.
by: Ulmert, D, et al.
Published: (2009)

Individual prognosis at diagnosis in nonmetastatic prostate cancer: Development and external validation of the PREDICT Prostate multivariable model.
by: David R Thurtle, et al.
Published: (2019-03-01)

Immunohistochemical Typing of Adenocarcinomas of the Pancreatobiliary System Improves Diagnosis and Prognostic Stratification.
by: Carlos Fernández Moro, et al.
Published: (2016-01-01)

Urinary symptoms and prostate cancer—the misconception that may be preventing earlier presentation and better survival outcomes
by: Vincent J. Gnanapragasam, et al.
Published: (2022-08-01)

Responses to provision of personalised cancer risk information: a qualitative interview study with members of the public
by: Juliet A. Usher-Smith, et al.
Published: (2017-12-01)

Correction: Immunohistochemical Typing of Adenocarcinomas of the Pancreatobiliary System Improves Diagnosis and Prognostic Stratification.
by: Carlos Fernández Moro, et al.
Published: (2017-01-01)

Prognostic Stratification of Prostatic Cancer According to Modified Gleason Grading System
by: Mir Attaullah
Published: (2016-12-01)

The association of herpes zoster and influenza vaccinations with the risk of developing dementia: a population-based cohort study within the UK Clinical Practice Research Datalink
by: Artitaya Lophatananon, et al.
Published: (2023-10-01)

Development and External Validation of the STRATified CANcer Surveillance (STRATCANS) Multivariable Model for Predicting Progression in Men with Newly Diagnosed Prostate Cancer Starting Active Surveillance
by: Alexander Light, et al.
Published: (2022-12-01)

Improved Prognostic Stratification Using Circulating Tumor Cell Clusters in Patients with Metastatic Castration-Resistant Prostate Cancer
by: Chun Wang, et al.
Published: (2021-01-01)

Combining Molecular Subtypes with Multivariable Clinical Models Has the Potential to Improve Prediction of Treatment Outcomes in Prostate Cancer at Diagnosis
by: Lewis Wardale, et al.
Published: (2022-12-01)

Identification and Validation of Leucine-rich α-2-glycoprotein 1 as a Noninvasive Biomarker for Improved Precision in Prostate Cancer Risk Stratification
by: Ingrid J. Guldvik, et al.
Published: (2020-10-01)

Investigation of the association between the antibody responses to neurotropic viruses and dementia outcomes in the UK Biobank
by: Krisztina Mekli, et al.
Published: (2022-01-01)

Investigation of the association between the antibody responses to neurotropic viruses and dementia outcomes in the UK Biobank.
by: Krisztina Mekli, et al.
Published: (2022-01-01)

Assessing the prognostic utility of smoldering multiple myeloma risk stratification scores applied serially post diagnosis
by: Alissa Visram, et al.
Published: (2021-11-01)

Biomarkers for prostate cancer detection and risk stratification
by: Mark W. Farha, et al.
Published: (2022-06-01)

Identification and validation of leucine-rich α-2-glycoprotein 1 as a noninvasive biomarker for improved precision in prostate cancer risk stratification
by: Guldvik, IJ, et al.
Published: (2020)

Prognostic significance of risk stratification in CHAARTED and LATITUDE studies among Japanese men with castration-resistant prostate cancer
by: Sotaro Chikamatsu, et al.
Published: (2022-03-01)

Integrating image guided-diagnostics, individualised prognostics and molecular profiling to identify targeted medicine strategies in men with aggressive primary non-metastatic prostate cancer
by: V.J. Gnanapragasam, et al.
Published: (2020-07-01)

Assessment of the Utility of Gene Positioning Biomarkers in the Stratification of Prostate Cancers
by: Karen J. Meaburn, et al.
Published: (2019-10-01)

Additional SNPs improve risk stratification of a polygenic hazard score for prostate cancer
by: Karunamuni, RA, et al.
Published: (2021)

Transperineal prostate biopsies for diagnosis of prostate cancer are well tolerated: a prospective study using patient-reported outcome measures
by: Karan Wadhwa, et al.
Published: (2017-01-01)

Biomarkers of systemic inflammation provide additional prognostic stratification in cancers of unknown primary
by: Svenja Harvey, et al.
Published: (2024-02-01)

Biomarkers for the Detection and Risk Stratification of Aggressive Prostate Cancer
by: Samaneh Eickelschulte, et al.
Published: (2022-12-01)

Radiogenomics influence on the future of prostate cancer risk stratification
by: Vinayak Banerjee, et al.
Published: (2022-09-01)

Prediction Medicine: Biomarkers, Risk Calculators and Magnetic Resonance Imaging as Risk Stratification Tools in Prostate Cancer Diagnosis
by: Daniël F. Osses, et al.
Published: (2019-04-01)

Reducing prostate biopsies and magnetic resonance imaging with prostate cancer risk stratification
by: Petter Davik, et al.
Published: (2022-09-01)

On Risk Estimation versus Risk Stratification in Early Prostate Cancer.
by: Sigrid V Carlsson, et al.
Published: (2016-08-01)

Risk Stratification in Primary Biliary Cholangitis
by: Francesco Martini, et al.
Published: (2023-09-01)

Relationship of self-reported body size and shape with risk for prostate cancer: A UK case-control study
by: Mohammad Aladwani, et al.
Published: (2020)

The entry ECG in the early diagnosis and prognostic stratification of patients with suspected acute myocardial infarction.
by: Yusuf, S, et al.
Published: (1984)

Cardiac Magnetic Resonance Features of Fabry Disease: From Early Diagnosis to Prognostic Stratification
by: Antonia Camporeale, et al.
Published: (2022-05-01)